SCHEMBL11226320

SCHEMBL11226320

Cc1c(-c2ccncc2)[nH]c2ccc(CCC(=O)O)c(CCCCCCCC(=O)O)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.42
CSNK1D P48730 1/20 0.42
CLK2 P49760 1/20 0.42
CSNK1G1 Q9HCP0 1/20 0.42
TBXAS1 P24557 8/20 0.40
LTB4R Q15722 3/20 0.39
CYP2C9 P11712 2/20 0.39
LTB4R2 Q9NPC1 1/20 0.39
PTK2 Q05397 3/20 0.38
HDAC2 Q92769 3/20 0.38
HDAC3 O15379 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
EGFR P00533 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
PPARG P37231 1/20 0.34
PDE2A O00408 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11168892 0.75 TBXAS1 (0.48) TBXAS1
SCHEMBL11168702 0.74 TBXAS1 (0.44) TBXAS1
SCHEMBL11167375 0.72 TBXAS1 (0.47) TBXAS1
SCHEMBL5146760 0.72 TBXAS1 (0.47) TBXAS1
SCHEMBL11070611 0.71 TBXAS1 (0.63) CSNK1A1CSNK1DCLK2CSNK1G1TBXAS1
SCHEMBL11172992 0.71 CYP11B1 (0.48) TBXAS1
SCHEMBL10532359 0.71 TBXAS1 (0.48) TBXAS1
Hydrochloric Acid SCHEMBL11005148 0.70 TBXAS1 (0.61) CSNK1A1CSNK1DCLK2CSNK1G1TBXAS1
Hydrochloric Acid SCHEMBL11097478 0.70 TBXAS1 (0.48) TBXAS1
SCHEMBL6922496 0.67 PPARG (0.50) CYP2C9EGFRALDH1A1CYP1A2PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0080154-A2 N-substituted 2-pyridyl indoles, process for their preparation, pharmaceutical compositions containing them, and their therapeutical use CIBA-GEIGY AG (CH) 1983-06-01 EP disclosed